Our finding of tumor cell enhanced antigen presentation machinery and antigen-specific CD8+ T cell cytotoxicity potentially may have overcome the dampening effect of Ezh2 inhibition on the function of CD8+ T cells. This evidence concerns the gene EZH2 and neoplasm.